Morgan Stanley

US firm International Flavors & Fragrances (IFF) has agreed to buy rival Frutarom in a debt-backed $7.1bn transaction, in what will be the second largest ever acquisition of an Israeli company.

China's Ascletis Pharma has emerged as the first biotechnology firm to test the waters of Hong Kong’s new listing regime, after filing a draft prospectus on Monday.

Real estate developer Vinhomes priced its D30.7tr ($1.35bn) listing at the top of guidance on Monday in Vietnam’s largest equity offering to date, according to a banker on the transaction.

A handful of Chinese investment grade rated state-owned companies are gauging investor appetite for new deals amid a weak market backdrop.

T-Mobile US has lined up $38bn of fully committed loans to finance its $26bn purchase of US telecommunications company Sprint.

Blackstone has cut its stake in Intertrust, the Dutch provider of trusts and fund services, after an accelerated bookbuild on Wednesday night.

There are two phrases that don’t often go together in the capital markets: ‘13% yield’ and ‘two year bond’. But that eye-watering funding cost was just what China’s Hydoo International Holding paid on its latest exchange offer, marking the highest yield for a dollar bond since 2015. Bankers think there will be plenty more where that came from, writes Addison Gong.

CEVA Logistics, the freight management and contract logistics company, priced its IPO on the SIX Swiss Exchange at the bottom of the range on Thursday.

Morgan Stanley’s private equity arm raised W230.4bn ($214.3m) from an overnight sell down in South Korea’s Hyundai Rotem on Wednesday.

Xiaomi Corp set its $10bn IPO in motion this week with an initial filing to the Hong Kong Stock Exchange. The move is a big win for the city, as the Chinese smartphone maker will be the first high-profile issuer to make use of Hong Kong’s new listing rules that allow founders to control a company with weighted voting rights (WVR). John Loh reports.

Demand for European IPOs is high but investors are refraining from putting money to work unless offered a sizeable discount.

India's IndoStar Capital Finance has announced an indicative price range for its potential Rp18.4bn ($276m) IPO, according to a banker on the deal.